Archive | Cardiovascular Disease RSS feed for this section
Computed tomography scan of the abdomen showing a saccular structure (as highlighted) at the confluence of the superior mesenteric vein and the splenic vein posterior to the pancreatic neck, measuring 36.5 mm × 53.7 mm × 52.1 mm. The mass enhances during the portal venous phase on contrast-enhanced computed tomography and is contiguous with the portal venous system. No compression of surrounding viscera appreciated. (A) Coronal section; (B) transverse section; (C and D) 3-dimensional reconstruction.

Massive Asymptomatic Extrahepatic Portal Vein Aneurysm

A 59-year-old woman with no prior liver disease or portal hypertension presented with an episode of right upper quadrant pain that lasted for 3 hours. The patient had a history of cholelithiasis, which was diagnosed 3 years earlier. She denied any other symptoms. Her social and family history were unremarkable. Assessment Her examination was remarkable […]

Read more
man shopping in a supermarket

Does Testerone Supplementation Impact Heart Disease Risk? (video)

Does testosterone supplementation impact heart disease risk? The March 2017 issue of the American Journal of Medicine includes a new meta-analysis that looks at the use of testosterone supplements and cardiovascular disease risk. In this video Dr. Joseph S. Alpert talks about testosterone supplements and risk. Read the Research: Cardiovascular Risks of Exogenous Testosterone Use […]

Read more
glowing-heart-stock

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease

To derive and validate a single metric of activity tracking that associates with lower risk of cardiovascular disease mortality. Methods We derived an algorithm, Personalized Activity Intelligence (PAI), using the HUNT Fitness Study (n = 4631), and validated it in the general HUNT population (n = 39,298) aged 20-74 years. The PAI was divided into three sex-specific […]

Read more
Risk of bias assessment of the included randomized controlled trials using the Cochrane Risk of Bias Tool.

Cardiovascular Risks of Exogenous Testosterone Use Among Men (videos)

We sought to evaluate whether exogenous testosterone therapy is associated with increased risk of serious cardiovascular events as compared with other treatments or placebo. Methods Study selection included randomized controlled trials (RCTs) and observational studies that enrolled men aged 18 years or older receiving exogenous testosterone for 3 or more days. The primary outcomes were […]

Read more

Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows (video)

Hypertrophic cardiomyopathy was first recognized as a disease of obstruction to left ventricular outflow, hence, its early names and acronyms such as idiopathic hypertrophic subaortic obstruction. The nonobstructive subset of patients, incapable of developing mechanical impedance to left ventricular outflow at rest or with physiologic exercise, was initially recognized by the Braunwald group at the […]

Read more
doctor-consultation-w-depressed-man-stock

Mental Health and Cardiovascular Disease

For centuries, the mind–body relationship has been postulated. These findings suggest that depression and anxiety are not simply “in the mind.” They are real illnesses, like any other physical illnesses, and can negatively impact the entire body, including the cardiovascular system. Despite the abundance of investigation and demonstration of a clear relationship between mental health […]

Read more
UA-42320404-1